Medirom Healthcare Technologies (MRM) said Monday that NFES Technologies agreed to be the lead investor in Medirom Mother Labs' series A financing round.
NFES Technologies' participation in the financing round, which values Mother Labs at 9 billion yen ($62.5 million) on a pre-money basis, is expected to attract additional investors, Medirom said.
The company said NFES Technologies will get the series A shares as a third-party allotment.
Shares of Medirom soared more than 178% in premarket activity Monday.
Price: 6.9100, Change: +4.43, Percent Change: +178.63
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.